Simvastatin-Associated Rhabdomyolysis Demonstrated on Bone Scan

Clinical Nuclear Medicine

Volumn 27, Issue 11, 2002, Pages 793-794

  Rhodes, Casey A ^a   Balon, Helena R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Bone Scan; Rhabdomyolysis; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; CREATINE KINASE MB; CYCLOSPORIN; CYTOCHROME P450 3A4; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; MACROLIDE; MEDRONATE TECHNETIUM TC 99M; MYOGLOBIN; NEFAZODONE; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BONE SCINTISCANNING; CASE REPORT; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; DRUG UPTAKE; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERLIPIDEMIA; MORTALITY; MYOPATHY; RHABDOMYOLYSIS; SCINTIGRAPHY; SIDE EFFECT; SKELETAL MUSCLE; WHOLE BODY SCANNER; ABDOMEN; CHEMICALLY INDUCED DISORDER; PELVIS; SCINTISCANNING; SHOULDER; THIGH; WHOLE BODY COUNTING;

ABDOMEN; AGED; ANTILIPEMIC AGENTS; FEMALE; HUMANS; HYPERLIPIDEMIAS; MUSCLE, SKELETAL; PELVIS; RADIOPHARMACEUTICALS; RHABDOMYOLYSIS; SHOULDER; SIMVASTATIN; TECHNETIUM TC 99M MEDRONATE; THIGH; WHOLE-BODY COUNTING;

EID: 0036832754     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200211000-00008     Document Type: Article

References (9)

1. Omar MA, Wilson JP, Cox TS: Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 35:1096, 2001.
2. Maron DJ, Fazio S, Linton MF: Current perspectives on statins. Circulation 101:207, 2000.
3. Herman R: Drug interactions and the statins. Can Med Assoc J 161:1281, 1999.
4. Hodel C: Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 128:159, 2002.
5. Omar MA, Wilson JP: FDA adverse event reports on statin-associated rhabdomyolysis. Ann Pharmacother 36:288, 2002.
6. Hamilton-Craig I: Statin-associated myopathy. Med J Aust 175:486, 2001.
7. Furberg CD, Pitt B: Withdrawal of cerivastatin from the world market. Curr Control Trials Cardiovasc Med 2:205, 2001.
8. Kamaliah MD, Sanjay LD: Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives. Singapore Med J 42:368, 2001.
9. Valk P: Muscle localization of Tc-99m MDP after exertion. Clin Nucl Med 9:493, 1984.